Correlation Between Pfizer and Atea Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pfizer and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Atea Pharmaceuticals, you can compare the effects of market volatilities on Pfizer and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Atea Pharmaceuticals.

Diversification Opportunities for Pfizer and Atea Pharmaceuticals

0.05

Correlation Coefficient

Pfizer  Atea Pharmaceuticals

Significant diversification

The 3 months correlation between Pfizer and Atea is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Pfizer i.e., Pfizer and Atea Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pfizer and Atea Pharmaceuticals

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Atea Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.95 times less risky than Atea Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Atea Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  333.00  in Atea Pharmaceuticals on December 27, 2024 and sell it today you would lose (15.00) from holding Atea Pharmaceuticals or give up 4.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Atea Pharmaceuticals

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Atea Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Atea Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Atea Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Pfizer and Atea Pharmaceuticals

The main advantage of trading using opposite Pfizer and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.

The idea behind Pfizer Inc and Atea Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.